Skip to main content
. 2017 Mar 17;8(23):37308–37320. doi: 10.18632/oncotarget.16307

Table 3. Logistic regression analyses of associations between PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms and risk of type 2 diabetes.

Genotype Cases(n=502) Controls(n=782) Crude OR (95%CI) P Adjusted OR a (95%CI) P
n % n %
PPARG rs1801282 C>G
CC 457 91.95 704 90.03 1.00 1.00
CG 40 8.05 76 9.72 0.80 (0.54-1.20) 0.280 0.76(0.50-1.14) 0.179
GG 0 0 2 0.26 - - - -
GC+GG 40 8.05 78 9.98 0.79 (0.53-1.18) 0.247 0.75 (0.50-1.12) 0.164
CC+GC 497 100 780 99.75 1.00 1.00
GG 0 0 2 0.26 - - - -
G allele 40 4.02 80 5.12
PPARG rs3856806 C>T
CC 278 55.94 474 60.61 1.00 1.00
CT 196 39.44 275 35.17 1.19 (0.94-1.51) 0.140 1.17(0.92-1.48) 0.204
TT 23 4.63 33 4.22 1.17 (0.67-2.03) 0.583 1.19 (0.68-2.08) 0.541
CT+TT 219 44.06 308 39.39 1.21 (0.97-1.52) 0.098 1.19 (0.94-1.50) 0.140
CC+CT 474 95.37 749 95.78 1.00 1.00
TT 23 4.63 33 4.22 1.10 (064-1.90) 0.728 1.14 (0.65-1.97) 0.653
T allele 242 24.35 341 21.80
PPARGC1A rs8192678 C>T
CC 138 27.77 250 31.97 1.00 1.00
CT 251 50.50 382 48.85 1.15 (0.89-1.49) 0.296 1.12 (0.86-1.46) 0.402
TT 108 21.73 150 19.18 1.26 (0.91-1.74) 0.161 1.22 (0.88-1.69) 0.240
CT+TT 269 54.12 532 68.03 1.22 (0.96-1.57) 0.111 1.19 (0.93-1.1.53) 0.178
CC+CT 389 78.27 632 80.82 1.00 1.00
TT 108 21.73 150 19.18 1.17 (0.89-1.54) 0.269 1.15(0.87-1.52) 0.334
T allele 467 46.98 682 43.61
PPARGC1A rs2970847 C>T
CC 310 62.37 485 62.02 1.00 1.00
CT 160 32.19 268 34.27 0.92 (0.72-1.17) 0.495 0.93 (0.73-1.19) 0.582
TT 27 5.43 29 3.71 1.43 (0.83-2.47) 0.194 1.50 (0.87-2.60) 0.148
CT+TT 187 37.63 297 37.98 0.99 (0.78-1.24) 0.899 1.00 (0.79-1.27) 0.979
CC+CT 470 94.57 753 96.29 1.00 1.00
TT 27 5.43 29 3.71 1.49 (0.87-2.55) 0.144 1.55(0.90-2.68) 0.112
T allele 214 21.53 326 20.84
PPARGC1A rs3736265 G>A
GG 380 76.61 557 71.41 1.00
GA 103 20.77 196 25.13 0.76(0.58-1.00) 0.049 0.76(0.58-1.00) 0.053
AA 13 2.62 27 3.46 0.70(0.36-1.37) 0.295 0.74(0.37-1.46) 0.378
GA + AA 116 23.39 223 28.59 0.76(0.59-0.99) 0.041 0.77(0.59-1.00) 0.050
GG+GA 483 97.38 753 96.54 1.00 1.00
AA 13 2.62 27 3.46 0.75(0.38-1.47) 0.403 0.79(0.40-1.56) 0.494
A allele 129 13.00 250 15.98
PPARGC1B rs7732671 G>C
GG 435 87.53 698 89.26 1.00 1.00
GC 61 12.27 81 10.36 1.20(0.84-1.70) 0.323 1.20(0.84-1.72) 0.314
CC 1 0.20 3 0.38 0.53(0.06-5.10) 0.582 0.48(0.05-4.71) 0.527
GC+CC 62 12.47 84 10.74 1.18(0.84-1.68) 0.342 1.19(0.83-1.69) 0.341
GG+GC 496 99.80 779 99.62 1.00 1.00
CC 1 0.20 3 0.38 0.52(0.05-5.05) 0.576 0.47(0.05-4.66) 0.520
C allele 63 6.34 87 5.56
PPARGC1B rs17572019 G>A
GG 435 87.53 698 89.26 1.00
GA 60 12.07 80 10.23 1.19(0.83-1.70) 0.338 1.19(0.83-1.71) 0.338
AA 2 0.40 4 0.51 0.79(0.15-4.35) 0.790 0.81(0.14-4.52) 0.808
GA+AA 62 12.47 84 10.74 1.18(0.84-1.68) 0.343 1.19(0.83-1.69) 0.341
GG+GA 495 99.60 778 99.49 1.00
AA 2 0.40 4 0.51 0.79(0.14-4.31) 0.781 0.80(0.14-4.49) 0.80
A allele 64 6.44 88 5.63

a Adjusted for age, sex, smoking status, alcohol use and BMI status.

Bold values are statistically significant (P <0.05).